Trident Texofab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 ,inter alia, to consider and approve Un-Audited Fincnail Result ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Trident Texofab Limited has informed BSE that its Board of Directors will meet on Thursday, February 12, 2026, at the registered office in Surat. The key agenda item is to consider and approve the Unaudited Standalone Financial Results for the quarter and nine months ended December 31, 2025 (Q3 FY26). The trading window for the company's equity shares has been closed since January 1, 2026, and will reopen 48 hours after the results are made public on February 12, 2026. The intimation was issued by Rahul Jariwala, Company Secretary and Compliance Officer, on February 6, 2026.
This is a routine pre-results intimation and does not contain any actual financial numbers, so there is no direct impact on shareholders at this stage. Investors should watch for the Q3 FY26 results on February 12, 2026, for actual performance details.